Effectiveness and Safety of Intranasal Ipratropium Bromide in Common Colds: A Randomized, Double-Blind, Placebo-Controlled Trial

Annals of Internal Medicine

Volumn 125, Issue 2, 1996, Pages 89-97

  Hayden, Frederick G ^a,b   Diamond, Louis ^c   Wood, Pauline B ^d   Korts, David C ^e   Wecker, Margaret T ^e  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF RHODE ISLAND   (United States)

^e BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IPRATROPIUM BROMIDE; MUSCARINIC RECEPTOR BLOCKING AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; FEMALE; HOSPITALIZATION; HUMAN; INTRANASAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SNEEZING; TIME; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; COMMON COLD; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IPRATROPIUM; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; RHINITIS; SEVERITY OF ILLNESS INDEX; SNEEZING; TIME FACTORS; TREATMENT OUTCOME;

EID: 0030585962     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-125-2-199607150-00002     Document Type: Article

References (29)

1. Sperber SJ, Hayden FG. Chemotherapy of rhinovirus colds. Antimicrob Agents Chemother. 1988;32:409-19.
2. Turner RB, Hendley JO, Gwaltney JM Jr. Shedding of infected ciliated epithelial cells in rhinovirus colds. J Infect Dis. 1982;145:849-53.
3. Naclerio RM, Proud D, Lichtenstein LM, Kagey-Sobotka A, Hendley JO, Sorrentino J, et al. Kinins are generated during experimental rhinovirus colds. J Infect Dis. 1988;157:133-42.
4. Proud D, Naclerio RM, Gwaltney JM, Hendley JO. Kinins are generated in nasal secretions during natural rhinovirus colds. J Infect Dis. 1990;161: 120-3.
5. Gwaltney JM Jr. Combined antiviral and antimediator treatment of rhinovirus colds. J Infect Dis. 1992;166:776-82.
6. Igarashi Y, Skoner DP, Doyle WJ, White MV, Fireman P, Kaliner MA. Analysis of nasal secretions during experimental rhinovirus upper respiratory infections. J Allergy Clin Immunol. 1993;92:722-31.
7. Raphael GD, Jeney EV, Baraniuk JN, Kim I, Meredith SD, Kaliner MA. Pathophysiology of rhinitis. Lactoferrin and lysozyme in nasal secretions. J Clin Invest. 1989;84:1528-35.
8. Gaffey MJ, Gwaltney JM Jr, Dressler WE, Sorrentino JV, Hayden FG. Intranasally administered atropine methonitrate treatment of experimental rhinovirus colds. Am Rev Respir Dis. 1987;135:241-4.
9. Gaffey MJ, Hayden FG, Boyd JC, Gwaltney JM Jr. Ipratropium bromide treatment of experimental rhinovirus infection. Antimicrob Agents Chemother. 1988;32:1644-7.
10. Gaffey MJ, Gwaltney JM Jr, Sastre A, Dressler WE, Sorrentino JV, Hayden FG. Intranasally and orally administered antihistamine treatment of experimental rhinovirus colds. Am Rev Respir Dis. 1987;136:556-60.
11. Borum P. Intranasal ipratropium: inhibition of methacholine induced hypersecretion. Rhinology. 1978;16:225-33.
12. Raphael GD, Druce HM, Baraniuk JN, Kaliner MA. Pathophysiology of rhinitis. 1. Assessment of the sources of protein in methacholine-induced nasal secretions. Am Rev Respir Dis. 1988;138:413-20.
13. Dockhorn R, Grossman J, Posner M, Zinny M, Tinkleman D. A double-blind, placebo-controlled study of the safety and efficacy of ipratropium bromide nasal spray versus placebo in patients with the common cold. J Allergy Clin Immunol. 1992;90(6 Pt 2):1076-82.
14. Diamond L, Dockhorn RJ, Grossman J, Kisicki JC, Posner M, Zinny MA, et al. A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold. J Allergy Clin Immunol. 1996;95(5 Pt 2):1139-46.
15. Parekh HH, Cragun KT, Hayden FG, Hendley JO, Gwaltney JM Jr. Nasal mucus weights in experimental rhinovirus infection. American Journal of Rhinology. 1992;3:107-10.
16. Borum P, Olsen L, Winther B, Mygind N. Ipratropium nasal spray: a new treatment for rhinorrhea in the common cold. Am Rev Respir Dis. 1981;123(4 Pt 1):418-20.
17. Leung AK, Robson WL. Sneezing. J Otolaryngol. 1994;23:125-9.
18. Howard JC Jr, Kantner TR, Lilienfield LS, Princiotto JV, Krum RE, Crutcher JE, et al. Effectiveness of antihistamines in the symptomatic management of the common cold. JAMA. 1979;242:2414-7.
19. Crutcher JE, Kantner TR. The effectiveness of antihistamines in the common cold. J Clin Pharmacol. 1981;21:9-15.
20. Gaffey MJ, Kaiser DL, Hayden FG. Ineffectiveness of oral terfenadine in natural colds: evidence against histamine as a mediator of common cold symptoms. Pediatr Infect Dis J. 1988;7:223-8.
21. Berkowitz RB, Tinkelman DG. Evaluation of oral terfenadine for treatment of the common cold. Ann Allergy. 1991;67:593-7.
22. Groth S, Dirksen H, Mygind N. The absence of systemic side-effects from high doses of ipratropium in the nose. Eur J Respir Dis. 1983;64(Suppl 128): 490-3.
23. Hayden FG, Hipskind GJ, Woerner DH, Eisen GF, Janssens M, Janssen PA, et al. Intranasal pirodavir (R77,975) treatment of rhinovirus colds. Antimicrob Agents Chemother. 1995;39;290-4.
24. Graham NM, Burrell CJ, Douglas RM, Debelle P, Davies L. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. J Infect Dis. 1990;162:1277-82.
25. Sperber SJ, Hendley JO, Hayden FG, Riker DK, Sorrentino JV, Gwaltney JM Jr. Effects of naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial. Ann Intern Med. 1992;117:37-41.
26. Smith MB, Feldman W. Over-the-counter cold medications. A critical review of clinical trials between 1950 and 1991. JAMA. 1993;269:2258-63.
27. Bye CE, Cooper J, Empey DW, Fowle AS, Hughes DT, Letley E, et al. Effects of pseudoephedrine and triprolidine, alone and in combination, on symptoms of the common cold. BMJ. 1980;281:189-90.
28. Berkowitz RB, Connell JT, Dietz AJ, Greenstein SM, Tinkelman DG. The effectiveness of the nonsedating antihistamine loratadine plus pseudoephedrine in the symptomatic management of the common cold. Ann Allergy. 1989;63:336-9.
29. 1-receptor-antagonist drugs. N Engl J Med. 1994;330:1663-70.